中基長壽科學(00767.HK)中期由盈轉虧2080萬港元
格隆匯8月30日丨中基長壽科學(00767.HK)發佈公吿,截至2021年6月30日止六個月,公司收益1611萬港元,同比減少23%;公司擁有人應占虧損2080萬港元,上年同期盈利1580萬港元;每股虧損0.54港仙。
期間額外授出的購股權為數13.1百萬港元,令回顧期內蒙受整體虧損20.9百萬港元。然而,長壽科學業務貢獻收益7.2百萬港元及淨溢利2.84百萬港元,為所蒙受整體虧損提供緩衝作用。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.